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2275Percutaneous coronary intervention (PCI) improves survival
in patients with acute myocardial infarction and has the
potential to reduce morbidity and improve quality of life in
other settings. The use of PCI accounts for approximately
600,000 procedures (1) and $12 billion in healthcare
spending annually in the United States (2). However, prior
studies have reported lower rates of PCI among blacks,
women, and those who have public or no health insurance
(3, 4). Whether these differences are due to underuse in
these traditionally vulnerable populations, or overuse in
whites, men, and those who have private health insurance, or
both, is unknown.See page 2282Now, with the development of the Appropriate Use
Criteria by national cardiovascular societies (5), there exists
a standardized approach to systematically assess the clinical
appropriateness of PCI. Recent studies applying these
criteria have found that rates of inappropriate PCI in the
United States range from 12% to 17% for stable patients
without acute coronary syndromes, but these studies did not
examine the patients or hospital characteristics associated
with procedures categorized as inappropriate (6–9). Illumi-
nating whether some of the observed differences in rates of
PCI by race, sex, or insurance status of the patients may be
due to PCIs considered by the Appropriate Use Criteria to
be inappropriate, can provide information to improve equity
in health care (10,11). This would suggest that efforts to
reduce healthcare differences will not simply mean raising
procedural rates for vulnerable populations, but also
improving its use in whites, men, and privately insured
patients. Thus, complex efforts would be required to address
both procedural underuse and overuse.
To address this current gap in knowledge, we analyzed
data from a large national PCI registry to examine whether
certain patient demographics and insurance status are asso-
ciated with inappropriate PCIs for nonacute indications. In
addition, we examined whether certain hospital factors, such
as location of hospital, hospital for-proﬁt status, academic
afﬁliation, and annual PCI volume, are associated with
higher rates of inappropriate PCIs.
Methods
Data source. The CathPCI Registry is an initiative of
the American College of Cardiology Foundation and The
Society for Cardiovascular Angiography and Interventions.
There are more than 1,500 participants submitting data
from diagnostic cardiac catheterization and PCI procedures
to the national registry. The design and salient characteris-
tics of the registry have been previously described (12–14).
Detailed information on patient characteristics, coronary
angiography, PCIs, and in-hospital outcomes is collected by
trained staff at participating hospitals using standardized
data elements. For CathPCI Registry, all submissions ofreported procedural data must
meet predetermined levels of
completeness and consistency for
data ﬁelds and internal quality
assurance protocols before the
information is entered into the
registry (14). In addition, the
National Cardiovascular Data
Registry has a robust data quality program that conducts
annual audits of data variables at 25 randomly selected sites.
In 2010, the CathPCI Registry found that the accuracy rate
of audited sites was 93.1% (range, 89.4% minimum and
97.4% maximum) for 58 target variables (14).
Appropriate use criteria. The methodology for developing
the Appropriate Use Criteria for coronary revascularization
that reﬂects a synthesis of contemporary clinical trial
evidence, clinical practice guidelines, and expert opinion, has
been previously described (5). Using a modiﬁed Delphi
approach, a 17-member expert panel adjudicated the ap-
propriateness of coronary revascularization compared with
medical therapy for 198 distinct clinical indications. From
the individual ratings of the technical panel members, each
clinical indication was classiﬁed as appropriate, uncertain, or
inappropriate. An “appropriate” rating denotes coronary
revascularization, as compared with medical therapy, would
likely improve a patient’s health status (symptoms, function,
or quality of life) or survival. An “uncertain” rating implies
that more research and/or patient information is needed to
further classify the indication. An “inappropriate” rating
indicates that the beneﬁts of coronary revascularization,
compared with medical therapy, may not outweigh the risks
of treatment (5). Each of these ratings were intended to
evaluate care of populations of patients with the under-
standing that any single patient case may have unmeasured
variables affecting clinical decision making. For this study,
we focused on the appropriateness of coronary revasculari-
zation with PCI, as the CathPCI Registry does not collect
information on coronary artery bypass surgery.
In our prior work, we developed algorithms for matching
PCI procedures from the CathPCI Registry to appropri-
ateness ratings from the Appropriate Use Criteria for
coronary revascularization (6). Although the Appropriate
Use Criteria have recently been updated, we used the orig-
inal criteria from 2009 (5) because these were operative at
the time that the majority of cases from this study were
conducted, and also because this approach is consistent with
the methodology we used in our original work (6).
Study population of stable ischemic heart disease patients
undergoing PCI. We examined 1,087,995 PCI procedures
between July 1, 2009 and March 31, 2011. Our prior work
had demonstrated that the vast majority of PCIs that were
rated inappropriate were performed for nonacute indica-
tions. Based on that work, we excluded acute PCIs (i.e.,
those performed for myocardial infarction and high-risk
unstable angina) and restricted our study cohort to the
426,880 patients who underwent a nonacute PCI during this
Figure 1 Study Cohort
Patients excluded from the study cohort are depicted. NCDR ¼ National Cardio-
vascular Data Registry; PCI ¼ percutaneous coronary intervention.
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2276study period (Fig. 1). We further excluded 173,187 PCIs in
which the requisite data for mapping patients to the
Appropriate Use Criteria were not available, primarily due to
the absence of noninvasive stress test results (89,634 who
proceeded to PCI without a stress test, 71,489 with a stress
test but without information on ischemia severity, and
12,064 unable to be matched to the Appropriate Use
Criteria). We also excluded 42,439 staged nonacute PCIs,
so that the analyses would reﬂect the practice patterns at
the time of an initial decision to proceed with PCI. Our
ﬁnal study cohort comprised 211,254 nonacute PCIs from
1,071 hospitals. Importantly, except for age, there were
no signiﬁcant differences in patient and hospital character-
istics between those who were excluded and those who
were included in the study cohort (Online Table 1).
Statistical analysis. The proportion of PCIs classiﬁed as
appropriate, uncertain, and inappropriate was determined
using a previously validated algorithm (6). Baseline demo-
graphics, clinical characteristics, and hospital factors of
patients undergoing PCI were then compared by appropri-
ateness category. Continuous variables were evaluated using
analysis of variance and categorical variables with the chi-
square test.
To examine whether patient demographics, insurance
status, and hospital factors were associated with in-
appropriate PCI, we constructed a 2-level multivariable
hierarchical logistic regression model, which allowed us to
account for patients from the same hospitals (15). In this
model, all patient and hospital characteristics were modeled
as ﬁxed effects, and each hospital site was modeled as
a random effect. Our primary independent variables of
interest in the model were age, sex, race (categorized as white,
black, or other), and insurance type (private, Medicare, otherpublic [e.g., Veterans Affairs, Medicaid, Indian Health
Service], and none). In addition to these 4 characteristics, in
our models, we included the following patient variables to
minimize potential confounding: active smoking, heart
failure exacerbation within the past 2 weeks, hypertension,
dyslipidemia, diabetes mellitus, chronic hemodialysis, family
history of coronary artery disease, left ventricular systolic
dysfunction (ejection fraction <40%), and a history of
myocardial infarction, PCI, coronary artery bypass surgery,
cardiac valve surgery, heart failure, peripheral arterial disease,
cerebrovascular disease, and chronic lung disease. In addition,
we included certain hospital factors as ﬁxed effects in the
model, including location (rural, suburban, urban), teaching
status, public versus private hospital, hospital type (private/
community, university, or government), availability of onsite
cardiothoracic surgery backup, mean door-to-balloon time
for ST-segment elevation myocardial infarction, and annual
nonacute PCI volume.
All tests for statistical signiﬁcance were 2-tailed and
evaluated at a signiﬁcance level of 0.05. All statistical anal-
yses were performed with the use of SAS 9.2 (SAS Institute,
Inc., Cary, North Carolina) or R version 2.10.0 (Vienna,
Austria).
Results
Of 211,254 nonacute PCIs, 105,121 (49.8%) were classiﬁed
by the Appropriate Use Criteria as appropriate, 80,384
(38.1%) as uncertain, and 25,749 (12.2%) as inappropriate.
Table 1 summarizes baseline characteristics of patients
undergoing PCI, stratiﬁed by appropriateness category.
Compared with patients who had appropriate PCIs, patients
who had inappropriate PCIs were more frequently men,
white, and privately insured. There were modest differences
by age. In addition, patients who underwent inappropriate
PCIs less likely had a prior myocardial infarction, PCI,
coronary artery bypass surgery, or valve surgery, a pre-
existing or recent heart failure, other cardiac comorbidities,
and/or left ventricular systolic dysfunction. They were also
more likely to have a pre-operative evaluation for noncardiac
surgery than patients who had PCIs that were categorized as
appropriate (8.9% vs. 2.6%; p < 0.001).
Table 2 summarizes the characteristics of hospitals at
which patients underwent PCIs that were stratiﬁed by
appropriateness. A greater proportion of patients undergoing
PCI at suburban hospitals were classiﬁed as having an
inappropriate PCI, as compared with patients at urban and
rural hospitals. Compared with patients who had PCIs that
were uncertain or appropriate, patients who had inappro-
priate PCIs were more commonly treated at hospitals that
performed fewer nonacute PCIs annually. Finally, there were
small differences observed across appropriateness categories
for teaching status, public hospital status, for-proﬁt status,
and the presence of onsite cardiothoracic surgery.
Factors associated with inappropriate PCI. After multi-
variable adjustment, we found that men (adjusted odds ratio
Table 1 Characteristics of Patients Undergoing PCI, Stratiﬁed by Appropriateness
Entire Cohort
(N ¼ 211,254)
Appropriate
(n ¼ 105,121)
Uncertain
(n ¼ 80,384)
Inappropriate
(n ¼ 25,749) p Value*
Demographics
Age 65.3  11.2 65.4  11.4 65.2  11.0 65.5  10.6 <0.001
Men 66.6% 66.6% 66.2% 68.3% <0.001
Race
White 88.9% 88.4% 89.1% 90.0% <0.001
Black 7.6% 7.7% 7.6% 7.2% 0.02
Other 3.5% 3.9% 3.3% 2.8% <0.001
Health Insurance <0.001
Medicare 67.5% 66.0% 68.0% 71.8%
Private 24.3% 24.9% 24.3% 22.1%
Other 5.4% 5.8% 5.1% 4.3%
None 2.9% 3.3% 2.6% 1.7%
Comorbidities
Current or recent smoker 22.0% 22.2% 22.1% 21.2% 0.002
Family history of CAD 25.1% 25.1% 25.8% 22.8% <0.001
Hypertension 86.3% 87.3% 85.6% 84.1% <0.001
Dyslipidemia 86.0% 86.4% 85.9% 84.9% <0.001
Diabetes mellitus 38.0% 39.5% 36.8% 35.4% <0.001
Prior heart failure 11.1% 12.8% 9.7% 8.3% <0.001
Heart failure in past 2 weeks 7.5% 8.5% 6.5% 6.3% <0.001
LVEF <40% 9.8% 11.0% 8.6% 8.5% <0.001
Prior myocardial infarction 28.8% 31.4% 27.3% 22.7% <0.001
Prior PCI 44.3% 47.0% 43.6% 35.4% <0.001
Prior CABG 13.9% 14.8% 13.5% 10.9% <0.001
Prior valve surgery 1.3% 1.3% 1.4% 1.4% 0.009
Cerebrovascular disease 12.6% 13.4% 11.8% 11.7% <0.001
Peripheral arterial disease 13.4% 14.0% 12.9% 12.7% <0.001
Chronic lung disease 14.9% 15.6% 14.5% 13.3% <0.001
Hemodialysis 2.1% 2.3% 1.9% 2.3% <0.001
Pre-operative evaluation 3.9% 2.6% 4.1% 8.9% <0.001
Values are mean  SD or %. *p values denote signiﬁcant differences across the 3 categories of appropriateness.
CABG ¼ coronary artery bypass graft surgery; CAD ¼ coronary artery disease; LVEF ¼ left ventricular ejection fraction; PCI ¼ percutaneous
coronary intervention.
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2277[OR]: 1.08; 95% conﬁdence interval [CI]: 1.05 to 1.11; p <
0.001) and white patients (adjusted OR: 1.09; 95% CI: 1.05
to 1.14; p < 0.001) were more likely to undergo an inap-
propriate PCI than women and nonwhites, respectively.
Compared with patients having private health insurance,
those who had Medicare (adjusted OR: 0.85; 95% CI: 0.83
to 0.88), other public insurance (adjusted OR: 0.78; 95% CI:
0.73 to 0.83), and no insurance (adjusted OR: 0.56; 95% CI:
0.50 to 0.61) were less likely to undergo an inappropriate
PCI (p < 0.001). There were no differences in rates of
inappropriate PCI by age (p ¼ 0.32). Notably, patients with
a family history of premature coronary artery disease, known
heart failure, left ventricular systolic dysfunction, and
a history of myocardial infarction or coronary revasculari-
zation were less likely to undergo an inappropriate PCI
(Table 3), whereas patients with a pre-operative evaluation
for noncardiac surgery were more likely to undergo an
inappropriate PCI (adjusted OR: 2.84; 95% CI: 2.69 to
2.99).
Several hospital characteristics were also associated with
inappropriate PCI after adjusting for patient characteristics.Compared with patients admitted at urban hospitals, those
admitted at rural hospitals (adjusted OR: 0.92; 95% CI: 0.88
to 0.96) were less likely to undergo an inappropriate PCI,
whereas those treated at suburban hospitals were more likely
to undergo inappropriate PCI (adjusted OR: 1.10; 95% CI:
1.07 to 1.13; p < 0.001). There was no association between
treatment at a teaching, public, or for-proﬁt hospital, and
onsite cardiothoracic surgery and rates of inappropriate PCI.
Although we found a statistically signiﬁcant association
between the annual elective PCI volume (per 100 cases) of
a hospital and inappropriate PCI, the adjusted OR was 0.99,
suggesting that these differences were not clinically signiﬁ-
cant. Notably, there were no signiﬁcant interactions between
a patient’s demographics or insurance status and hospital
factors (all p > 0.10).
Finally, the 7 most common indications for an inappro-
priate PCI from the 2009 Appropriate Use Criteria are
described (Online Fig. 1), with each indication comprising
>500 PCI cases in the study cohort. The most frequent
indications for an inappropriate PCI were indications 12 and
14, in which PCIs were performed in patients who had no
Table 2 Characteristics of Hospitals for Patients Undergoing PCI, Stratiﬁed by Appropriateness
Entire Cohort
(N ¼ 211,254)
Appropriate
(N ¼ 211,254)
Uncertain
(n ¼ 80,384)
Inappropriate
(n ¼ 25,749) p Value*
Hospital location <0.001
Rural 10.2% 10.2% 10.3% 9.7%
Suburban 30.8% 29.4% 31.8% 33.0%
Urban 59.0% 60.4% 57.8% 57.2%
Teaching hospital 50.4% 51.0% 50.0% 49.1% <0.001
Public hospital 58.4% 59.3% 57.1% 58.4% <0.001
For-proﬁt status <0.001
Government 0.7% 0.8% 0.7% 0.6%
Private 87.4% 86.8% 87.9% 87.9%
Nonproﬁt 11.9% 12.4% 11.5% 11.5%
Onsite cardiothoracic surgery 88.4% 89.0% 87.4% 88.5%
Elective PCI volume, no. per year 843  706 872  702 836  740 748  592 <0.001
Door-to-balloon time for STEMI 74.4  21.5 74.1  22.5 74.9  20.9 74.3  18.6 <0.001
Values are % or mean  SD. *p values denote signiﬁcant differences across the 3 categories of appropriateness.
STEMI ¼ ST-segment elevation myocardial infarction; other abbreviations as in Table 1.
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2278prior history of coronary artery bypass surgery, single to 2-
vessel non–high-risk CAD, minimal to no anti-anginal
therapy, and either a low-risk or intermediate-risk study
for ischemia. Among these 7 most common indications for
an inappropriate PCI, those with higher rates among men,
whites, privately-insured patients, and suburban patients are
described in Table 4.
Discussion
Although prior studies have described differences in use of
medical procedures by race and sex, it has not been clear
whether these treatment differences were solely attributable
to underuse in vulnerable populations or also overuse in
others (10). In this large, national PCI registry, we found
that men, whites, and those with private health insurance
were more likely to undergo a PCI for stable coronary artery
disease that was classiﬁed by consensus-based criteria as
inappropriate. There were also differences in a patient’s
likelihood of receiving an inappropriate PCI based on
whether their treating hospital was located in a suburban,
urban, or rural area. Finally, we found that patients without
heart failure, left ventricular dysfunction, or known coronary
artery disease, as well as patients undergoing pre-operative
evaluation for noncardiac surgery, were more likely to
undergo a PCI categorized as inappropriate. Collectively,
these ﬁndings provide important insights into which patient
and hospital characteristics are associated with a PCI for
stable coronary artery disease in whom the risks of the
procedure may exceed its beneﬁts.
By leveraging the recently developed Appropriate Use
Criteria for coronary revascularization, we were able to extend
the existing literature that has documented less PCI use in
women and blacks by showing that, in the setting of stable
ischemic heart disease, these patients are less likely to undergo
inappropriate procedures. Men were 8% more likely to havean inappropriate PCI than women, and whites were 9% more
likely to have an inappropriate PCI than blacks. Although the
clinical magnitude of these differences was modest, it repre-
sents more than 2,000 additional procedures per year in
which men and white patients may be exposed to procedural
and long-term bleeding risks without clear clinical beneﬁt in
comparison to that of medical therapy (Online Table 2).
Importantly, these data suggest that prior reports of racial and
sex differences in PCI rates may not be solely due to underuse
(i.e., disparities), but also overuse (10).
In contrast to the modest differences by patient demo-
graphic characteristics, we found substantially larger differ-
ences in inappropriate PCI by insurance status and treatment
location. Compared with patients who have private health
insurance, those who have Medicare and other public insur-
ance were 15% and 22% less likely to undergo a nonacute PCI
classiﬁed as inappropriate, respectively, and uninsured
patients were nearly half as likely to undergo such procedures.
We also found that the location of the hospital was associated
with large differences in the rates of inappropriate PCI, even
after adjusting for patient demographics, insurance, and
clinical characteristics. Patients admitted to rural hospitals
were the least likely to undergo a PCI without clear clinical
beneﬁt, whereas patients admitted at suburban hospitals were
the most likely. The reason for this treatment pattern is
unknown but may be related to decreased availability of
interventional cardiologists at rural hospitals or different
cultures of practice and patient preferences within different
hospital settings. Interestingly, we did not ﬁnd an association
between a hospital’s for-proﬁt or teaching status and
a patient’s likelihood of undergoing an inappropriate PCI, nor
did we ﬁnd a clinically meaningful relationship with a hospi-
tal’s nonacute PCI case volume.
The lower rate of inappropriate PCIs in blacks, women, the
uninsured, or those residing in rural locations may suggest
that these patients are treated later in the course of their
Table 3 Patient and Hospital Predictors of Inappropriate PCI
Adjusted OR (95% CI) p Value
Demographics
Age, per 10 yrs 1.01 (0.99–1.02) 0.32
Men 1.08 (1.05–1.11) <0.001
White 1.09 (1.05–1.14) <0.001
Health insurance (reference: private) <0.001
Medicare 0.85 (0.83–0.88)
Other public insurance 0.78 (0.73–0.83)
None 0.56 (0.50–0.61)
Clinical variables
Smoker 1.00 (0.97–1.04) 0.99
Hypertension 0.90 (0.87–0.93) <0.001
Dyslipidemia 1.05 (1.01–1.09) 0.02
Family history of CAD 0.89 (0.86–0.92) <0.001
Prior myocardial infarction 0.84 (0.81–0.86) <0.001
Prior heart failure 0.83 (0.79–0.87) <0.001
Prior valve surgery 1.11 (0.99–1.25) 0.06
Prior PCI or CABG 0.73 (0.70–0.75) <0.001
Hemodialysis 0.98 (0.90–1.08) 0.71
Cerebrovascular disease 0.96 (0.92–1.00) 0.05
Peripheral arterial disease 0.97 (0.93–1.01) 0.17
Chronic lung disease 0.93 (0.89–0.97) <0.001
Diabetes mellitus 0.93 (0.90–0.96) <0.001
Heart failure in past 2 weeks 0.95 (0.90–1.01) 0.12
Pre-operative evaluation 2.84 (2.69–2.99) <0.001
Left ventricular systolic dysfunction 0.93 (0.89–0.98) 0.008
Hospital variables
Hospital location (reference: urban) <0.001
Rural 0.92 (0.88–0.96)
Suburban 1.10 (1.07–1.13)
Teaching hospital 0.98 (0.95–1.01) 0.11
Public hospital 1.02 (0.99–1.05) 0.25
For-proﬁt status (reference: university) 0.28
Government 0.87 (0.74–1.04)
Private 1.00 (0.96–1.05)
Onsite cardiothoracic surgery 1.03 (0.99–1.08) 0.20
Annual elective PCI volume per 100 cases 0.99 (0.99–0.99) <0.001
Mean door-to-balloon time for STEMI, per 10 min 0.99 (0.98–1.00) 0.002
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 1 and 2.
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2279coronary artery disease than those who had greater access to
care. As a result, these patient groups may be more symp-
tomatic orwere given amore robust trial of anti-angina therapy
prior to coronary angiography and PCI, thus leading to lower
rates of inappropriate procedures. This pattern of care among
traditionally vulnerable populations would not be intrinsically
problematic, as it may simply reﬂect good clinical decision
making, as long as it is also not accompanied by concurrent
underuse of PCIs for appropriate indications. Moreover, for
whites, men, privately insured patients, and those in suburban
locations to have higher rates of inappropriate PCI, our ﬁnd-
ings suggest that these patient groups are undergoing PCI
more frequently with only mild to no angina, low-risk stress
tests, and/or insufﬁcient trials of anti-angina therapy.
Finally, we found that patients evaluated for noncardiac
surgery were more likely to undergo inappropriate PCIs.
Use of PCIs in this setting is inconsistent with the ﬁndingsof the CARP (Coronary Artery Revascularization Prophy-
laxis) trial, which demonstrated that coronary revasculari-
zation prior to even the highest risk noncardiac surgeries
(i.e., vascular surgeries involving aortic aneurysms or
femoral-popliteal artery bypasses) did not reduce rates of
death or myocardial infarction (16). Given the common use
of drug-eluting stents in contemporary practice and the
requirements for dual antiplatelet therapy with any stent for
30 days or greater, the use of PCI in stable patients prior to
noncardiac surgery may not only deviate from the ﬁndings
of the CARP trial, but it may also increase bleeding risk.
Nevertheless, avoiding PCIs that may not confer a clear
clinical beneﬁt in pre-operative patients can be complex and
challenging, as it involves not only the cardiologist, but also
the referring physicians and surgeon. Therefore, efforts to
reduce inappropriate PCIs in pre-operative patients will
require concerted efforts to provide educational outreach to
Table 4 Distribution of Inappropriate PCIs by Indication and Subgroup*
Proportion of Study Sample
Appropriate Use Criteria Indication Number
12
(n ¼ 14,824)
13
(n ¼ 758)
14
(n ¼ 5,999)
19
(n ¼ 613)
48
(n ¼ 686)
54
(n ¼ 1,338)
56
(n ¼ 688)
Demographics
Sex
Male 66.6% 65.9% 59.0% 72.3% 54.2% 80.6% 77.1% 83.9%
Female 33.4% 34.1% 41.0% 27.7% 45.8% 19.4% 22.9% 16.1%
Insurance
Private 67.5% 73.1% 66.8% 70.7% 65.9% 70.6% 71.2% 69.0%
Medicare 24.4% 20.6% 27.2% 24.3% 22.0% 26.1% 23.2% 27.0%
Other 5.4% 4.4% 4.2% 3.9% 8.2% 2.9% 4.4% 3.3%
None 2.9% 2.0% 1.8% 1.2% 3.9% 0.4% 1.2% 0.6%
Race
White 88.9% 90.0% 82.3% 89.8% 90.5% 92.7% 91.7% 94.3%
Black 7.6% 7.0% 14.8% 7.4% 7.5% 4.7% 5.0% 3.6%
Other 3.5% 3.0% 2.9% 2.8% 2.0% 2.5% 3.3% 2.1%
Hospital location
Suburban 30.8% 32.8% 31.4% 33.5% 32.0% 33.5% 35.4% 35.3%
Urban 59.0% 57.2% 61.2% 57.5% 53.2% 56.4% 55.4% 57.7%
Rural 10.2% 10.0% 7.4% 9.0% 14.8% 10.1% 9.3% 7.0%
Values are %. *The most common indications for inappropriate PCI (>500 cases) in the study cohort are displayed by sex, race, insurance status, and hospital location. Values in bold show if the proportion of
inappropriate PCI was higher for men, whites, privately insured patients, and those who were treated at suburban locations.
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2280primary care physicians, cardiologists, and noncardiac
surgeons alike.
Our study should be interpreted in the context of the
following limitations. First, the results of the present analysis
apply only to the stable PCI population, which represents
w40% of procedures in the CathPCI Registry; therefore,
these results cannot be extrapolated to PCI of patients with
acute coronary syndromes, in whom overall rates of inap-
propriate PCI are extremely low (w1%). Moreover, although
our ﬁndings suggest potential overuse of PCI in men, whites,
and those who had private health insurance, they do not
diminish the critical importance of efforts to reduce previously
documented underuse of PCIs in blacks, women, and those
who had public or no insurance. However, the CathPCI
Registry does not contain data on all patients potentially
eligible for coronary revascularization. As a result, we could
not assess for underuse of PCI (17,18) or determine what the
“right rates” (avoiding overuse and reducing underuse) should
be for coronary revascularization with PCI.
Although our analyses were conducted in a patient sample
from more than 1,000 hospitals, not all hospitals that perform
PCI in the United States participate in the National Cardio-
vascular Data Registry CathPCI Registry. Our study also
excluded nonacute procedures without an assessment of
ischemia risk, which is an inherent limitation in the design and
application of the Appropriate Use Criteria. However, it is
noteworthy that theAppropriateUseCriteria reﬂect a synthesis
of contemporary clinical trial evidence, clinical practice guide-
lines, and expert opinion, and readily acknowledge that some
inappropriate procedures may be considered uncertain or
appropriate when considering unique clinical and patient
factors (e.g., coronary anatomy) not covered by the indications.
An additional potential concern is that we were unable toexamine the failure of medical therapy or the inﬂuence of
patient preferences in determining treatment with PCI.
Finally, data in the CathPCI Registry are not 100% audited, so
there is the possibility of miscoding of data elements, although
data accuracy has been shown to be generally high (14).
Conclusion
We found that 1 in 8 PCIs in stable patients were classiﬁed
as inappropriate by the Appropriate Use Criteria for Coro-
nary Revascularization, and these procedures were more
commonly performed in men, whites, those who had private
insurance, and patients who were admitted to hospitals in
suburban locations. Although underuse of treatment leads to
disparities in care, our ﬁndings suggest potential overuse of
PCI in these patient groups may also account for some of the
previously observed differences in care.
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